Robert Langer
罗伯特·兰格
ScD
David H. Koch Institute Professor, Department of Chemical Engineering大卫·科赫学院教授，化学工程系
👥Biography 个人简介
World's most cited engineer and pioneer of controlled drug delivery. Co-invented lipid nanoparticle (LNP) technology foundational to mRNA cancer vaccines and COVID-19 vaccines. Holds over 1,400 patents; member of all four US National Academies.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Lipid Nanoparticle mRNA Delivery
Co-developed LNP formulations enabling stable mRNA encapsulation and intracellular delivery, directly enabling personalized mRNA cancer vaccines and the mRNA COVID-19 vaccine platform.
Controlled-Release Cancer Therapy
Pioneered polymer-based implantable drug delivery systems, including GLIADEL wafer for glioblastoma, transforming local chemotherapy delivery and reducing systemic toxicity.
Representative Works 代表性著作
An mRNA Vaccine against SARS-CoV-2 — Preliminary Report
New England Journal of Medicine (2020)
Foundational LNP-mRNA delivery study that established the platform used for personalized cancer vaccine approaches.
Nanocarriers as an Emerging Platform for Cancer Therapy
Nature Nanotechnology (2007)
Landmark review defining nanocarrier design principles for targeted cancer drug delivery, cited thousands of times.
🏆Awards & Recognition 奖项与荣誉
📄Data Sources 数据来源
Last updated: 2026-01-15 | All information from publicly available academic sources
Related Experts 相关专家
Faisal Mahmood
Brigham and Women's Hospital; Harvard Medical School
Kun-Hsing Yu
Harvard Medical School; Brigham and Women's Hospital
Ziad Obermeyer
University of California, Berkeley; UC San Francisco
Andrew H. Beck
PathAI; Harvard Medical School (formerly)
关注 罗伯特·兰格 的研究动态
Follow Robert Langer's research updates
留下邮箱，当我们发布与 Robert Langer（Massachusetts Institute of Technology）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment